{"organizations": [], "uuid": "5a91b09e471693e6db01a38ed700a52d8f58f8d1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-initiator-pharma-reports-q4-ebit-l/brief-initiator-pharma-reports-q4-ebit-loss-at-dkk-3-9-million-idUSFWN1QB08I", "country": "US", "domain_rank": 408, "title": "BRIEF-Initiator Pharma Reports Q4 EBIT Loss At DKK 3.9​ Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.496, "site_type": "news", "published": "2018-02-21T15:04:00.000+02:00", "replies_count": 0, "uuid": "5a91b09e471693e6db01a38ed700a52d8f58f8d1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-initiator-pharma-reports-q4-ebit-l/brief-initiator-pharma-reports-q4-ebit-loss-at-dkk-3-9-million-idUSFWN1QB08I", "ord_in_thread": 0, "title": "BRIEF-Initiator Pharma Reports Q4 EBIT Loss At DKK 3.9​ Million", "locations": [], "entities": {"persons": [{"name": "furt", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Initiator Pharma A/S:\n* Q4 EBIT LOSS DKK 3.9​ MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T15:04:00.000+02:00", "crawled": "2018-02-22T18:05:18.051+02:00", "highlightTitle": ""}